CCL5 and prostate cancer: In vivo, PC-3 xenografted SCID mice injected with THP-1-derived TAMs showed a significant increase in bone metastasis while CCL5 knockdown blocked bone metastasis from prostate cancer, suggesting CCL5 as a major contributor to prostate cancer migration [19].